Executive Summary
Global Plasma Fractionation Market valued approximately USD 19 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2017-2025. Key factors which are providing growth to the market are the increasing use of immunoglobulins in several therapeutic areas, increasing respiratory diseases, growing geriatric population across the world, and AATD driving the approval of alpha-1-antitrypsin, and growing plasma collection. However, limited reimbursement policies and high cost, are the major restraining factor which hinder the growth of this market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Products:
- Immunoglobulin
- Coagulation Factor Concentrates
- Albumin
- Protease Inhibitors
- Others
By Application:
- Neurology
- Immunology
- Homology
- Critical Care
- Pulmonology
- Hemoto-Oncology
- Rheumatology
- Others
By End Use:
- Hospitals & Clinics
- Clinical Research Laboratories
- Academic Institutes
Furthermore, years considered for the study are as follows:
- Historical year – 2015
- Base year – 2016
- Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market CSL, Grifols, Shire, Octapharma, Kedrion, LFB, Biotest, Sanquin, China Biologic Products, Bio Prodcuts Laboratory (BPO), Japan Blood Products Organization, Green Cross Corporation, Shanghai Raas Blood Products Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Plasma Fractionation Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Request Sample Report @ https://www.wiseguyreports.com/sample-request/3180973-global-plasma-fractionation-market-size-study-by-product
Table of Contents
Chapter 1. Global Plasma Fractionation Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
Chapter 4. Global Plasma Fractionation Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Plasma Fractionation Market, By Product
Chapter 6. Global Plasma Fractionation Market, By Application
Chapter 7. Global Plasma Fractionation Market, By End Use
Chapter 8. Global Plasma Fractionation Market, by Regional Analysis
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. CSL
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Grifols
9.3.3. Shire
9.3.4. Octapharma
9.3.5. Kedrion
9.3.6. LFB
9.3.7. Biotest
9.3.8. Sanquin
9.3.9. China Biologic Products
9.3.10. Bio Prodcuts Laboratory (BPO)
9.3.11. Japan Blood Products Organization
9.3.12. Green Cross Corporation
9.3.13. Shanghai Raas Blood Products
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/3180973-global-plasma-fractionation-market-size-study-by-product
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com